Sunnyvale, CA. (PRWEB) April 09, 2013
The sixth session of the Silicon Valley BioTalks tackles the debate “Is EDC becoming a commodity?” The event takes place on April 17 at Onyx Pharmaceuticals headquarters in South San Francisco from 5.30pm – 8.00pm PDT and includes expert panelists from Onyx Pharmaceuticals, Clinical Leader, Clinovo and MedStars. The panel discussion will be simultaneously streamed online.
Described as “a truly informative panel discussion” and “a great forum to hear very experienced clinical trial professionals,” the Silicon Valley BioTalks is the venue for clinical trial professionals looking to stay ahead of trends and technologies in the life science industry. Over 60 healthcare industry professionals attended the most recent sessions, on CDISC standards, systems integration, and FDA regulations.
Wednesday, April 17 - 5.30pm – 8.00pm PDT
The event is free of charge with registration before April 12, 2013: clinovo.com/biotalks
Hosted at Onyx Pharmaceuticals.
The panel is composed of EDC experts Eric Morrie, Manager of Clinical Programming at Onyx Pharmaceuticals, Dr. Omar Dawood of Clinical Leader, Marc Desgrousilliers, CTO at Clinovo and Dr. Bob Molinari, CEO of Retrotype & Partner at MedStars. They will share insights on the evolution of the EDC market over the last 10 years, key players and influencers in the field, best practices for a successful implementation, and how EDC is evolving in today’s marketplace.
With clinical research one of the most expensive areas of drug development, Electronic Data Capture (EDC) has become an increasingly popular solution to lowering costs. Studies suggest that using EDC systems drastically reduces data
Copyright©2012 Vocus, Inc.
All rights reserved